In Brief: Chantal stock
This article was originally published in The Rose Sheet
Executive Summary
Chantal stock: NASDAQ small capital market trading suspended for the skin care company Feb. 26 after the firm's stock failed to maintain a closing bid price of greater than or equal to $1 per share. In its Feb. 17 10-Q filing with SEC, Chantal says it has brought in crisis management advisors to evaluate the July to December retail marketing operations and to make final an agreement with its distributor Stanson, with which Chantal terminated distribution in principle in June. The company is also seeking help in negotiating with creditors, many of which have filed lawsuits regarding Chantal's payment delinquencies. For the fiscal second quarter (ended Dec. 31), the firm reported a revenues decline to $1.6 mil., compared to $3.8 mil. in the prior-year period, and a net loss of $1 mil. versus a loss of $1.4 mil. a year ago...